As the mRNA technology used in the current Pfizer, BioNTech, and Moderna emergency use ( EUA ) experimental “vaccines” makes its way into arms around the world, little has been reported about how the messenger RNA technology—whose purpose is to instruct the immune system to fight COVID-19 —was developed. For the product to get “safely into human cells, ” the mRNA needs to be encapsulated in fragments of fat called lipids. As Pfizer CEO Albert Bourla disclosed to Forbes :
“The whole mRNA platform is not how to build an mRNA molecule; that’s the easy thing. It is how to make sure the mRNA molecule will go into your cells and give the instructions.”
As reported by UncoverDC, developing vaccines against COVID-19 is a hugely profitable endeavor for pharmaceutical companies. In fact, for years to come, Pfizer, BioNTech, and Moderna are expected to receive billions of dollars from COVID-19 booster shots alone, in a market that is expected to be similar to the $6 billion in annual sales for flu vaccines. The same three companies are projected to sell $45 billion worth of vaccines in 2021.
Exactly how did Moderna and Pfizer develop the technology to get their mRNA drugs […]
All ORIGINAL content on this site is © 2021 NOQ Report. All REPUBLISHED content has received direct or implied permission for reproduction.
With that said, our content may be reproduced and distributed as long as it has a link to the original source and the author is credited prominently. We don’t mind you using our content as long as you help out by giving us credit with a prominent link. If you feel like giving us a tip for the content, we will not object!
JD Rucker – EIC